Concepedia

Aleigha Lawless

AL

Statistics

Publications

10

Citations

486

H-Index

10

Active since

2021

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Broad Institute

Melanoma Institute Australia

The University of Sydney

Aleigha Lawless is an author at Massachusetts General Hospital specializing in medicine, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

2021–2025

10

Publications

10

Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma

James R. Patrinely, Rebecca Johnson, Aleigha Lawless et al. · JAMA Oncology · 2021 · 235 citations · Full text

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Mariko Takahashi, Harrison B. Chong, Siwen Zhang et al. · Cell · 2024 · 75 citations · Full text

, , +5

Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma

Rachel Goodman, Aleigha Lawless, Rachel Woodford et al. · JAMA Network Open · 2023 · 56 citations · Full text

Immune responses in checkpoint myocarditis across heart, blood and tumour

Steven M. Blum, Daniel A. Zlotoff, Neal P. Smith et al. · Nature · 2024 · 40 citations

, , +10

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study

Xue Bai, Shaheen Ahmed, Charlotte Grieco et al. · EClinicalMedicine · 2023 · 24 citations · Full text

, , +9

1–5 of 10